US Drug Recall Register
Class II · Moderate risk Ongoing Initiated Feb 20, 2024 (3 years ago)

Methylprednisolone acetate Injectable Suspension, USP, 400mg per 5mL (80mg/mL, 5mL…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Dissolution Specifications

What was recalled

Methylprednisolone acetate Injectable Suspension, USP, 400mg per 5mL (80mg/mL, 5mL Multiple-Dose Vial, Rx only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, NDC 55150-314-01

Recalling firm
Eugia US LLC
NDC code
55150-314-01
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0366-2024

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Methylprednisolone recalls

See all